however, no substantial progress has been made in clinical practice
PubMed 37364590 Regulatory status: Cagrilintide is not an approved human medicinal product in any regulatory zone (FDA, EMA, KL) as of the publication date
FDA-approved tirzepatide and injectable semaglutide products were on the shortage list
Other Antidiabetics Before the advent of GLP-1 agonists, the landscape of diabetes treatment was dominated by other classes of medications, such as metformin and sulfonylureas
Am J Physiol Gastrointest Liver Physiol 282(3):G424GG31 Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM et al (2003) Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction